Swiss National Bank Raises Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Swiss National Bank boosted its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 0.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 188,100 shares of the company’s stock after acquiring an additional 1,700 shares during the quarter. Swiss National Bank’s holdings in Privia Health Group were worth $3,677,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Intech Investment Management LLC bought a new position in Privia Health Group during the 3rd quarter valued at approximately $462,000. Charles Schwab Investment Management Inc. boosted its stake in Privia Health Group by 6.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,064,224 shares of the company’s stock worth $19,380,000 after purchasing an additional 65,152 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in Privia Health Group during the 3rd quarter valued at about $1,206,000. FMR LLC increased its stake in Privia Health Group by 1.5% during the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company’s stock valued at $330,858,000 after purchasing an additional 271,645 shares in the last quarter. Finally, Quantbot Technologies LP raised its holdings in Privia Health Group by 82.6% in the third quarter. Quantbot Technologies LP now owns 37,375 shares of the company’s stock worth $681,000 after buying an additional 16,904 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Wall Street Analyst Weigh In

PRVA has been the subject of a number of recent analyst reports. Macquarie initiated coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price objective for the company. JPMorgan Chase & Co. increased their price objective on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Needham & Company LLC restated a “buy” rating and set a $30.00 target price on shares of Privia Health Group in a research note on Friday, March 21st. Canaccord Genuity Group lifted their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. Finally, Piper Sandler raised their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, February 28th. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Privia Health Group presently has a consensus rating of “Buy” and an average price target of $26.67.

Privia Health Group Stock Performance

Shares of Privia Health Group stock opened at $22.75 on Wednesday. The stock’s fifty day moving average is $23.75 and its 200 day moving average is $21.11. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $26.04. The stock has a market cap of $2.74 billion, a P/E ratio of 227.52, a P/E/G ratio of 3.47 and a beta of 0.85.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.